Loading patent…
AssigneeLaboratori Derivati Organici S.p.A.
InventorsDonata BENSI, Giovanni CAGLIO
Estimating the term…
The present invention is directed to a composition comprising from 0.1 to 10.0 wt % of a mixture of glycosaminoglycans comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95% by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95% by weight, based on the total amount of glycosaminoglycans. Furthermore, the invention is also directed to the use of a glycosaminoglycans composition comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95% by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95% by weight, based on the total amount of glycosaminoglycans, as an anti-age composition.
Composition comprising from 0.1 to 10.0 wt % of a mixture of glycosaminoglycans comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95% by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95% by weight, based on the total amount of glycosaminoglycans, and wherein the composition comprises less than 5% hyaluronic acid, wherein the weight ratio of dermatan sulfate to chondroitin sulfate is comprised between 50/50 and 90/10.
A method of administering a glycosaminoglycan composition comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95% by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95% by weight, based on the total amount of glycosaminoglycans, and wherein the composition comprises less than 5% hyaluronic acid, as an anti-age composition or an anti-wrinkle composition .
A glycosaminoglycans mixture comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 20% and not more than 90% by weight, and the amount of chondroitin sulfate is at least 10% and not more than 80% by weight, based on the total amount of glycosaminoglycans, wherein dermatan sulfate and chondroitin sulfate together are present in an amount that is at least 40 wt % of the total amount of GAGs, the amount of heparin is lower than 5 wt % and wherein the composition is substantially free of hyaluronic acid, wherein the weight ratio of dermatan sulfate to chondroitin sulfate is comprised between 50/50 and 90/10.
Dependencies are inferred from the claim text.